|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 41.01 USD | +0.34% |
|
-6.94% | +39.06% |
| Jan. 30 | Leerink Partners Adjusts Moderna Price Target to $17 From $18, Maintains Underperform Rating | MT |
| Jan. 30 | Mib Outperforms Europe Ahead of S&P, Campari Leads Gains | AN |
Group Moderna, Inc.: Relations chart
Private companies belonging to the same group as MODERNA, INC.
| Company | Manager |
|---|---|
ModernaTX, Inc.
 ModernaTX, Inc. Develops messenger RNA therapeutics | Stéphane Bancel |
Moderna Switzerland GmbH | - |
Select your edition
All financial news and data tailored to specific country editions
